DETECT Study reaches 25th enrolment as momentum builds
Filed with ASX · · 3 pages · English
Earlier from Epiminder
- 1H FY26 Results Presentation
- 1H FY26 Results Announcement
- 1HFY26 Appendix 4D and Financial Report
- Quarterly Activities/Appendix 4C Cash Flow Report
- First Implant of Minder System in the US
Later from Epiminder
- Trading Update
- FY26 Investor Presentation
- FY26 Appendix 4E and Annual Report
- 75th DETECT Enrollee
- 100th patient enrolled in US study ahead of schedule
Follow Epiminder into a list and get an email when it puts out news.
Follow Epiminder